BREAST参与者的临床表现进展:测试集参与的影响
本研究纳入39名2010至2018年间为BreastScreen New South Wales阅片的BreastScreen Reader Assessment Strategy参与者,比较其完成首个测试集前两年与完成后三个时期的临床审计指标。结果显示,放射科医生在后续筛查轮次的召回率、阳性预测值1(PPV1)和特异度上平均有显著改善(p<0.05);按年均阅片量中位数3688分为两组后,高阅片量组在召回率、PPV1、浸润性乳腺癌及导管原位癌(DCIS)检出率上均有显著改善。
要点
- 参与乳腺X线测试集后,放射科医生在后续筛查中的召回率、PPV1和特异度平均显著改善(p<0.05)。
- 高阅片量组(高于中位数3688)在召回率、PPV1、浸润性乳腺癌和DCIS检出率上均显著改善。
- 低阅片量组仅在召回率和PPV1上于三个比较时期之一出现显著变化。
核心结论
- 乳腺X线测试集参与者的表现随时间改善,体现在识别正常乳腺筛查片和检出乳腺癌上,且与阅读更高数量的乳腺筛查病例相关。
研究设计与样本
- 研究纳入39名BreastScreen Reader Assessment Strategy参与者,均有2010至2018年间为BreastScreen New South Wales阅片的临床审计历史;以完成首个测试集的年份为界,比较测试集阅读前两个日历年与完成后三个不同时期的多个临床审计指标;另按阅片量中位数3688将放射科医生分为高、低阅片量两组重复分析。
诊断标准与关键数值
- 平均而言,放射科医生在后续筛查轮次的召回率、阳性预测值1(PPV1)和特异度上显示显著改善(p<0.05)。
- 高阅片量组在召回率、PPV1、浸润性乳腺癌检出率和导管原位癌(DCIS)检出率上显示显著改善。
- 低阅片量组在召回率和PPV1上显示显著变化,且均出现在三个比较时期之一。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To investigate if positive changes in the clinical performance of radiologists are associated with reading mammographic test sets.
MATERIALS AND METHODS: This study investigated the clinical audit history for a cohort of 39 participants in the BreastScreen Reader Assessment Strategy who have read for BreastScreen New South Wales in the period between 2010 and 2018, inclusively. Based on the year in which each radiologist completed his or her first test set, data of multiple clinical audit metrics from two calendar years before test-set reading were compared against similar data from three different periods after test-set completion. The same process was repeated after dividing radiologists into two subgroups based on their median screen-reading volume (3,688), to test if experience is a determinant of post-test set performance.
RESULTS: On average, radiologists showed significant improvements (p<0.05) in the recall rate for subsequent screening rounds, in positive predictive value 1 (PPV1), and in specificity. When dividing radiologists based on their average annual reading volume, radiologists with higher reading numbers demonstrated similar significant improvements in the recall rate and in PPV1. In addition, they showed significant improvements in the detection rates of invasive breast cancer and ductal carcinoma in situ (DCIS). In contrast, the radiologists with lower reading volume indicated significant changes in the recall rate and in PPV1, both accruing in one of the three compared periods.
CONCLUSION: Mammographic test-set participants improve over time in identifying normal breast screens and detecting breast cancer in association with reading higher volumes of breast screening cases.
引用
- Qenam, Li, Frazer, et al. Clinical performance progress of BREAST participants: the impact of test-set participation. Clin Radiol. 2021. PMID: 34801223. doi:10.1016/j.crad.2021.10.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。